33 - ANÁLISIS DE LOS TRATAMIENTOS SUBSIGUIENTES ANTINEOPLÁSICOS DEL ESTUDIO DE FASE 3 HIMALAYA: TREMELIMUMAB MÁS DURVALUMAB EN EL CARCINOMA HEPATOCELULAR AVANZADO O IRRESECABLE

View at publisher Summarise with VIRAT
Authors: Bruno Sangro, Ghassan K. Abou‐Alfa, Stephen L. Chan, George K.K. Lau, Masatoshi Kudo, Valeriy Breder, Maria Varela, Oxana Crysler, Mohamed Bouattour, Tu Van Dao, Adilson A. Faccio, Junji Furuse
+7 more Long-Bin Jeng, Yoon Koo Kang, Robin Kate Kelley, Hitomi Nakamura, J. Schmidt, Sajid Ali, Lorenza Rimassa
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies

Publication details

Journal / source
Gastroenterología y Hepatología
Volume
49
Pages
113244–113244
Publication date
1 February 2026
Language
EN